oxazolidin-2-one has been researched along with ro13-9904 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, SL; Lamberth, LB; Mason, EO | 1 |
| Cammarata, SK; Oliphant, TH; San Pedro, GS; Todisco, T | 1 |
| Attanasio, V; Conte, M; Faella, F; Fusco, U; Pagliano, P | 1 |
| Brown, KR; Edmiston, CE; Goheen, MP; Johnson, CP; Lewis, BD; Seabrook, GR; Towne, JB | 1 |
| Beşirbellioğlu, AB; Coşkun, O; Eyigün, CP; Gül, HC; Ors, F; Savaşci, U | 1 |
| Cucurachi, L; Sperber, SA | 1 |
| Amsler, K; Arbit, D; Balis, D; File, TM; Kaul, P; Michiels, B; Nicholson, SC; Noel, GJ; Strauss, RS; Welte, T | 1 |
| Cocuzza, C; Fortuna, CG; Guarcello, A; Musumeci, R; Pace, A; Palumbo Piccionello, A; Pierro, P | 1 |
| Dembo, T; Kato, Y; Takeda, H; Tanahashi, N | 1 |
| Fisher, MA; Hanson, KE; Schlaberg, R | 1 |
| Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C | 1 |
| Alm, RA; Le, WJ; Li, S; Liu, YR; Mueller, JP; Rice, PA; Su, XH; Wan, C; Wang, BX | 1 |
| Chong, Y; Lee, H; Lee, K | 1 |
| Batteiger, BE; Hook, EW; Johnson, SM; Kwak, H; Lawrence, K; Long, J; Marrazzo, J; Mueller, J; Seña, AC; Taylor, SN; Wierzbicki, MR | 1 |
| Aanensen, D; Ahlstrand, J; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sánchez-Busó, L; Unemo, M | 1 |
2 review(s) available for oxazolidin-2-one and ro13-9904
| Article | Year |
|---|---|
Delayed recurrent ischemic stroke after initial good recovery from pneumococcal meningitis.
Topics: Acetamides; Brain Damage, Chronic; Brain Ischemia; Ceftriaxone; Community-Acquired Infections; Constriction, Pathologic; Dexamethasone; Disease Progression; Drug Therapy, Combination; Humans; Linezolid; Male; Meningitis, Pneumococcal; Meropenem; Middle Aged; Oxazolidinones; Platelet Aggregation Inhibitors; Prednisolone; Recurrence; Thienamycins | 2012 |
New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Drug Resistance, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Isoxazoles; Macrolides; Morpholines; Neisseria gonorrhoeae; Neisseriaceae Infections; Oxazolidinones; Pharyngitis; Spectinomycin; Spiro Compounds; Triazoles | 2016 |
4 trial(s) available for oxazolidin-2-one and ro13-9904
| Article | Year |
|---|---|
Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Cefpodoxime; Ceftizoxime; Ceftriaxone; Community-Acquired Infections; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Infusions, Intravenous; Italy; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Pneumococcal; Probability; Streptococcus pneumoniae; Treatment Outcome | 2002 |
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Disease Eradication; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2012 |
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Barbiturates; Ceftriaxone; Female; Female Urogenital Diseases; Gonorrhea; Humans; Injections, Intramuscular; Intention to Treat Analysis; Isoxazoles; Male; Male Urogenital Diseases; Microbial Sensitivity Tests; Middle Aged; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Pharyngeal Diseases; Rectal Diseases; Sexual Partners; Spiro Compounds; Treatment Outcome; Young Adult | 2018 |
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Gonorrhea; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2021 |
9 other study(ies) available for oxazolidin-2-one and ro13-9904
| Article | Year |
|---|---|
In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillins; Streptococcus pneumoniae | 1996 |
Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains.
Topics: Acetamides; Adult; Aged; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Meningitis, Pneumococcal; Middle Aged; Oxazolidinones; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Blood Vessel Prosthesis; Ceftriaxone; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus; Vancomycin | 2006 |
[A case of meningitis emerged as a complication of hidradenitis suppurativa].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Buttocks; Ceftriaxone; Cerebrospinal Fluid; Gram-Positive Cocci; Hidradenitis Suppurativa; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones | 2009 |
Meningococcemia presenting as acute painful mononeuritis multiplex.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Electrodiagnosis; Electromyography; Female; Fever; Humans; Linezolid; Meningococcal Infections; Mononeuropathies; Neisseria meningitidis; Neural Conduction; Neurologic Examination; Oxazolidinones; Pain; Sepsis; Sural Nerve | 2012 |
Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship | 2012 |
Susceptibility profiles of Nocardia isolates based on current taxonomy.
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Oxazolidinones; Phylogeny; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2015 |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gene Expression; Gonorrhea; Humans; Isoxazoles; Male; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds; Tetracycline; Topoisomerase II Inhibitors; Urethritis | 2016 |